Doolabh Vaishali
Contemporary Plastic Surgery, Jacksonville, Fla.
Plast Reconstr Surg Glob Open. 2019 Nov 20;7(11):e2502. doi: 10.1097/GOX.0000000000002502. eCollection 2019 Nov.
Although tumescent liposuction provides debulking of body areas with excess subcutaneous fat and concurrent skin laxity, the ability to shrink and redrape the skin and soft tissue for added definition has remained an elusive goal. Many modalities employed to facilitate fat removal utilizing light energy, ultrasonic energy, or radiofrequency energy have provided modest skin shrinkage. Apyx Medical's (formerly Bovie Medical) Renuvion (previously branded as J-Plasma) has Food and Drug Administration clearance for the cutting, coagulation, and ablation of soft tissue. The objective of this retrospective chart review was to collect safety and procedural information for patients who have previously undergone liposuction with which Renuvion was used as a tool for subdermal coagulation. All procedures occurred before August 2018. Thirty-two patients were identified (3 male and 29 female). The mean follow-up was 6 months (range, 3-8 months). None of the patients required a revision or secondary procedure suggesting 100% of patients had acceptable final outcomes. No device-related adverse events or complications were noted, suggesting that within this data set, Renuvion's unique cool helium plasma technology can safely be used for skin contraction with or without tumescent liposuction or supplemental modalities used to facilitate fat removal that may otherwise contribute to the skin contraction.
尽管肿胀吸脂术能减少皮下脂肪过多区域的体积，并同时改善皮肤松弛问题，但收缩和重新塑形皮肤及软组织以增加轮廓清晰度的能力仍是一个难以实现的目标。许多利用光能、超声能或射频能来辅助脂肪去除的方法，仅能带来适度的皮肤收缩效果。Apyx Medical公司（前身为Bovie Medical）的Renuvion（曾用品牌名J-Plasma）已获得美国食品药品监督管理局的批准，可用于软组织的切割、凝血和消融。本回顾性病历审查的目的是收集那些先前接受过吸脂术且使用Renuvion进行皮下凝血的患者的安全性和手术相关信息。所有手术均在2018年8月之前进行。共确定了32例患者（3例男性和29例女性）。平均随访时间为6个月（范围为3 - 8个月）。没有患者需要进行修复手术或二次手术，这表明100%的患者最终结果均可接受。未观察到与设备相关的不良事件或并发症，这表明在该数据集中，无论是否联合肿胀吸脂术或用于辅助脂肪去除的补充方法（这些方法可能会导致皮肤收缩），Renuvion独特的冷氦等离子体技术都可安全用于皮肤收缩。
